Logo image of SPXC

SPX TECHNOLOGIES INC (SPXC) Stock Fundamental Analysis

NYSE:SPXC - New York Stock Exchange, Inc. - US78473E1038 - Common Stock - Currency: USD

168.95  +1.27 (+0.76%)

After market: 168.95 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPXC. SPXC was compared to 128 industry peers in the Machinery industry. While SPXC has a great profitability rating, there are quite some concerns on its financial health. SPXC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SPXC had positive earnings in the past year.
In the past 5 years SPXC has always been profitable.
SPXC had a positive operating cash flow in 4 of the past 5 years.
SPXC Yearly Net Income VS EBIT VS OCF VS FCFSPXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 6.46%, SPXC is doing good in the industry, outperforming 64.06% of the companies in the same industry.
SPXC has a Return On Equity of 14.04%. This is in the better half of the industry: SPXC outperforms 68.75% of its industry peers.
SPXC has a Return On Invested Capital of 9.04%. This is in the better half of the industry: SPXC outperforms 60.94% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SPXC is below the industry average of 10.71%.
The last Return On Invested Capital (9.04%) for SPXC is above the 3 year average (7.42%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROIC 9.04%
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
SPXC Yearly ROA, ROE, ROICSPXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

SPXC's Profit Margin of 10.13% is fine compared to the rest of the industry. SPXC outperforms 69.53% of its industry peers.
SPXC's Profit Margin has improved in the last couple of years.
The Operating Margin of SPXC (15.66%) is better than 75.00% of its industry peers.
SPXC's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 40.59%, SPXC is doing good in the industry, outperforming 74.22% of the companies in the same industry.
In the last couple of years the Gross Margin of SPXC has grown nicely.
Industry RankSector Rank
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
SPXC Yearly Profit, Operating, Gross MarginsSPXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

SPXC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SPXC has been increased compared to 1 year ago.
Compared to 5 years ago, SPXC has more shares outstanding
The debt/assets ratio for SPXC has been reduced compared to a year ago.
SPXC Yearly Shares OutstandingSPXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPXC Yearly Total Debt VS Total AssetsSPXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SPXC has an Altman-Z score of 4.03. This indicates that SPXC is financially healthy and has little risk of bankruptcy at the moment.
SPXC has a better Altman-Z score (4.03) than 67.19% of its industry peers.
SPXC has a Debt/Equity ratio of 0.65. This is a neutral value indicating SPXC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, SPXC is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.03
ROIC/WACC0.89
WACC10.13%
SPXC Yearly LT Debt VS Equity VS FCFSPXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

SPXC has a Current Ratio of 1.88. This is a normal value and indicates that SPXC is financially healthy and should not expect problems in meeting its short term obligations.
SPXC has a Current ratio of 1.88. This is comparable to the rest of the industry: SPXC outperforms 42.19% of its industry peers.
SPXC has a Quick Ratio of 1.24. This is a normal value and indicates that SPXC is financially healthy and should not expect problems in meeting its short term obligations.
SPXC's Quick ratio of 1.24 is in line compared to the rest of the industry. SPXC outperforms 50.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.24
SPXC Yearly Current Assets VS Current LiabilitesSPXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.38% over the past year.
Measured over the past years, SPXC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.24% on average per year.
SPXC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.94%.
SPXC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.40% yearly.
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%

3.2 Future

The Earnings Per Share is expected to grow by 13.43% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.39% on average over the next years. This is quite good.
EPS Next Y15.61%
EPS Next 2Y13.59%
EPS Next 3Y12.17%
EPS Next 5Y13.43%
Revenue Next Year11.62%
Revenue Next 2Y9.42%
Revenue Next 3Y10.13%
Revenue Next 5Y8.39%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SPXC Yearly Revenue VS EstimatesSPXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
SPXC Yearly EPS VS EstimatesSPXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.64 indicates a quite expensive valuation of SPXC.
Compared to the rest of the industry, the Price/Earnings ratio of SPXC indicates a slightly more expensive valuation: SPXC is more expensive than 60.16% of the companies listed in the same industry.
SPXC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.21.
A Price/Forward Earnings ratio of 23.51 indicates a rather expensive valuation of SPXC.
The rest of the industry has a similar Price/Forward Earnings ratio as SPXC.
When comparing the Price/Forward Earnings ratio of SPXC to the average of the S&P500 Index (21.70), we can say SPXC is valued inline with the index average.
Industry RankSector Rank
PE 29.64
Fwd PE 23.51
SPXC Price Earnings VS Forward Price EarningsSPXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPXC is valued a bit more expensive than 65.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.12
SPXC Per share dataSPXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SPXC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SPXC may justify a higher PE ratio.
SPXC's earnings are expected to grow with 12.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.9
PEG (5Y)1.94
EPS Next 2Y13.59%
EPS Next 3Y12.17%

0

5. Dividend

5.1 Amount

No dividends for SPXC!.
Industry RankSector Rank
Dividend Yield N/A

SPX TECHNOLOGIES INC

NYSE:SPXC (7/1/2025, 9:09:27 PM)

After market: 168.95 0 (0%)

168.95

+1.27 (+0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners94.98%
Inst Owner Change1.41%
Ins Owners3.24%
Ins Owner Change7.59%
Market Cap7.89B
Analysts86.15
Price Target178.67 (5.75%)
Short Float %1.82%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.73%
Min EPS beat(2)-1.85%
Max EPS beat(2)15.31%
EPS beat(4)3
Avg EPS beat(4)6.29%
Min EPS beat(4)-1.85%
Max EPS beat(4)15.31%
EPS beat(8)6
Avg EPS beat(8)8.98%
EPS beat(12)10
Avg EPS beat(12)14.23%
EPS beat(16)13
Avg EPS beat(16)11.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)7
Avg Revenue beat(12)1.46%
Revenue beat(16)7
Avg Revenue beat(16)0.38%
PT rev (1m)5.02%
PT rev (3m)3.77%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-5.31%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)2.49%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 29.64
Fwd PE 23.51
P/S 3.94
P/FCF N/A
P/OCF N/A
P/B 5.47
P/tB N/A
EV/EBITDA 21.12
EPS(TTM)5.7
EY3.37%
EPS(NY)7.19
Fwd EY4.25%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS42.85
BVpS30.9
TBVpS-7.72
PEG (NY)1.9
PEG (5Y)1.94
Profitability
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROCE 11.81%
ROIC 9.04%
ROICexc 9.68%
ROICexgc 33.47%
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
FCFM N/A
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
ROICexc(3y)7.93%
ROICexc(5y)6.67%
ROICexgc(3y)26.34%
ROICexgc(5y)19.42%
ROCE(3y)9.52%
ROCE(5y)8.03%
ROICexcg growth 3Y80.68%
ROICexcg growth 5Y32.98%
ROICexc growth 3Y48.19%
ROICexc growth 5Y15.92%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
F-ScoreN/A
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 2.3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.24
Altman-Z 4.03
F-ScoreN/A
WACC10.13%
ROIC/WACC0.89
Cap/Depr(3y)37.86%
Cap/Depr(5y)37.56%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
EPS Next Y15.61%
EPS Next 2Y13.59%
EPS Next 3Y12.17%
EPS Next 5Y13.43%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%
Revenue Next Year11.62%
Revenue Next 2Y9.42%
Revenue Next 3Y10.13%
Revenue Next 5Y8.39%
EBIT growth 1Y40.05%
EBIT growth 3Y57.13%
EBIT growth 5Y22.75%
EBIT Next Year29.82%
EBIT Next 3Y14.68%
EBIT Next 5Y15.57%
FCF growth 1Y34.29%
FCF growth 3Y14.53%
FCF growth 5Y13.64%
OCF growth 1Y37.12%
OCF growth 3Y17.87%
OCF growth 5Y13.98%